The websites listed at the end of this summary may have other information about
adverse reactions or other medical problems that happened during this study.
Did any adverse reactions happen during this study?
Benralizumab Placebo
(out of 427 participants) (out of 229 participants)
How many participants had adverse reactions? 16.9% (72) 8.7% (20)
How many participants had serious adverse 0.9% (4) 0.0% (0)
reactions?
How many participants stopped taking study 0.9% (4) 0.0% (0)
treatment due to adverse reactions?
What serious adverse reactions happened during this study?
The table below shows the serious adverse reactions that happened during the
study.
Serious adverse reactions
Benralizumab Placebo
Serious adverse reaction (out of 427 participants) (out of 229 participants)
A type of severe inflammatory immune system 0.2% (1) 0.0% (0)
reaction called “cytokine release syndrome”
Dilated eyes 0.2% (1) 0.0% (0)
Pneumonia 0.2% (1) 0.0% (0)
Raised itchy rash, also known as “hives” or “welts” 0.2% (1) 0.0% (0)
None of the participants died because of serious adverse reactions.
10 | Clinical Study Results